Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.

Authors :: Leoncini PP
Vitullo P
Di Florio F
Tocco V
Cefalo MG
Pitisci A
Girardi K
Niemeyer C
Locatelli F
Bertaina A
Source :: British journal of haematology [Br J Haematol] 2018 Sep; Vol. 182 (6), pp. 909-912. Date of Electronic Publication: 2017 Aug 02.
Publication Year :: 2018

Subjects :: Antigens, CD34 blood
Azacitidine therapeutic use
Binding Sites
Child
Child, Preschool
CpG Islands
Epigenesis, Genetic drug effects
Female
Humans
Leukemia, Myelomonocytic, Juvenile drug therapy
Leukemia, Myelomonocytic, Juvenile genetics
Male
Sequence Analysis, DNA
Azacitidine adverse effects
DNA Methylation drug effects
Leukemia, Myelomonocytic, Juvenile therapy

Full Text Access

Tools